Porsche's ultra-efficient headlamp technology will allow for 600 metres of illumination in high-beam mode, with 32,768 individual pixels 👀
, the new technology differs significantly from that used by current Porsche models, with the high beam function now carried out by two separate light sources in each assembly., says the move was driven by a desire to further emphasise the four-point styling that has become a signature design element of the German car maker in recent years.
By comparison, Porsche’s existing single-unit LED matrix system offers 84 pixels per headlight, or a combined 168 pixels. The breakthrough that has allowed Porsche to package the high beam function of its new HD matrix LED headlight into two separate units is new micro-LED technology. Each LED is described as having the thickness of a human hair, allowing 8192 separate LEDs or pixels to be packaged in each of the light sources.
United States Latest News, United States Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Donkervoort F22: 750kg supercar arrives with £211k price tag | AutocarThe 750kg Donkervoort F22 has arrived with 493bhp, promising to be the world's lightest two-seat supercar 🔥
Read more »
McLaren technology arm showcases first premium e-scooter | AutocarWith technology developed from McLaren F1 cars, the Lavoie Series 1 is the firm's first premium e-scooter
Read more »
Skoda removes Octavia PHEV from sale due to order backlog | AutocarA backlog of orders has resulted in the plug-in hybrid Skoda Octavia being temporarily removed from sale, with no timescale put on its return
Read more »
WSJ News Exclusive | Amgen in Advanced Talks to Buy Horizon TherapeuticsAmgen is in advanced talks to buy drugmaker Horizon Therapeutics, people familiar with the matter say, in a deal likely to be valued at well over $20 billion
Read more »
Safety and efficacy of avapritinib in advanced systemic mastocytosis: the phase 1 EXPLORER trial - Nature MedicinePresented at ASH21: In the phase 1 EXPLORER trial, avapritinib, a selective KIT inhibitor, was generally well tolerated and elicited durable clinical and molecular responses in patients with advanced systemic mastocytosis MPNsm ASH22
Read more »
For Minorities With PE: Less Advanced Treatment, More MortalityNon-White patients with pulmonary embolism were less likely to get advanced therapies, and Hispanics and Asians/Pacific Islanders, had higher death rates than Whites, new data show. ASH22
Read more »